256
Participants
Start Date
July 26, 2023
Primary Completion Date
October 4, 2025
Study Completion Date
November 30, 2025
ABP 206
ABP 206 will be given intravenously over a period of 30 minutes, every 4 weeks (Q4W) for a total of 12 months.
FDA-licensed Nivolumab
FDA-licensed Nivolumab will be given intravenously over a period of 30 minutes, Q4W for a total of 12 months.
EU-authorized Nivolumab
FDA-licensed Nivolumab will be given intravenously over a period of 30 minutes, Q4W for a total of 12 months.
Fundación CENIT, CABA
Instituto de Oncologia de Rosario, Rosario
Wits Clinical Research, Parktown, Johannesburg
Medical Oncology Cent of Rosebank, Johannesburg
Cape Town Oncology Trials, Kraaifontein
CIMMDP, Mar del Plata
Rondebosch Oncology Centre, Cape Town
"KBC Sestre milosrdnice", Zagreb
Hanoi Oncology Hospital, Hanoi
Hospital San Pedro de Alcántara, Cáceres
Charité - Universitätsmedizin Berlin KöR, Berlin
King Chulalongkorn Memorial Hospital [Medical Oncology], Bangkok
Siriraj Hospital, Bangkok
Military Medical Academy, Belgrade
Specialized hospital Oncomed System, Belgrade
Taipei Municipal Wanfang Hospital - Managed by Taipei Medical University, Taipei
Oncare Viaducto Napoles, Mexico City
Hospital Universiti Sains Malaysia, Kubang Kerian
University Clinical Center Nis, Niš
Centro de Inv Medica Aguascalientes, Aguascalientes
Ospedale San Raffaele, IRCCS, Milan
Istituto Europeo di Oncologia IRCCS, Milan
CHU de Poitiers, Poitiers
ASST Sette Laghi - Ospedale di Circolo Fondazione Macchi, Varese
University of Maryland Medical Center-Greenebaum Cancer Ctr, Baltimore
Vojvodina Institute for Oncology, Kamenitz
Taipei Medical University - Shuang Ho Hospital Ministry of Health and Welfare, New Taipei City
ASST Papa Giovanni XXIII, Bergamo
Fondazione IRCCS Policlinico San Matteo, Pavia
M.D. Anderson Center Madrid, Madrid
H.U.V.Arrixaca, El Palmar
AdventHealth, Orlando
University Clinical Center Kragujevac, Kragujevac
Khon Kaen University, Srinagarind Hospital, Khonkaen
China Medical University Hospital - Internal Medicine, Taichung
Hospital Universitario Virgen De La Macarena, Seville
Centro Inmuno Oncolog de Occidente, Guadalajara
Consorcio Hospital General Universitario de Valencia, Valencia
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.R.L, Meldola
Inje University Haeundae Paik Hospital, Busan
University Hospital Cologne AöR, Cologne
Azienda ospedaliero Universitaria Senese - Policlinico Le Scotte, Siena
Hospital Canselor Tuanku Muhriz UKM, Kuala Lumpur
Institut Kanser Negara, Putrajaya
I CAN ONCOLOGY CENTER SA de CV, Monterrey
Althian Research Management Center, San Pedro Garza García
Centro Medico Zambrano Hellion, San Pedro Garza García
HCM Oncology Hospital, Ho Chi Minh City
"Istituto dei Tumori Giovanni Paolo II", Bari
Clinical Center University of Sarajevo, Sarajevo
Cantonal hospital Zenica, Zenica
Clinica Integral Internac Oncologia, Puebla City
University Clinical Center Tuzla, Tuzla
University Clinical Centre of the Republic of Srpska - Gastroenterology, Banja Luka
Ctro At Inv Cardio Potosi, San Luis Potosí City
Azienda Ospedaliera Universitaria Federico II, Napoli
University Clinical Hospital Mostar, Mostar
Prince of Songkla University - Faculty of Medicine, Songkhla
Cancer and Blood Specialty Clinic, Long Beach
Hopital Ambroise Paré - Dermatologie, Boulogne-Billancourt
Hospital Umum Sarawak, Kuching
Centro De Atenc E Inv Clín En Onco, Mérida
Vietnam National Cancer Hopsital, Hanoi
Arensia - Iocn, Cluj-Napoca
Oncocentro APYS, Viña del Mar
Centro de Estudios Clínicos SAGA SpA, Santiago
The Lundquist Institute - Main, Torrance
St. Vincent Frontier Cancer Crt, Billings
Clínica Viedma, Viedma
ISIS Clinica Especializada, Santa Fe
Centro de Oncologia Leonardo da Vinci -ATO Oncologia, Fortaleza
Hospital Sao Rafael, Salvador
Instituto de Oncologia do Parana, Curitiba
Hospital Pulau Pinang, Pulau Pinang
Hospital Umum Sarawak, Kuching
Hospital Kuala Lumpur, Kuala Lumpur
Clinical Research Institute S.C., Tlalnepantla
Institute for Oncology and Radiology of Serbia, Belgrade
Hospital Sirio Libanes - Brasilia, Brasília
Centro de Tratamento Oncologico, Belém
Hospital Sao Lucas da PUCRS, Porto Alegre
CEPON - Centro de Pesquisas Oncológicas, Florianópolis
Hospital de Cancer de Barretos, Barretos
Fac Med de Sao Jose do Rio Preto, São José do Rio Preto
Hospital e Maternidade Brasil, São Paulo
Instituto Nacional de Câncer - INCA, Rio de Janeiro
University Hospital Centre Zagreb, Zagreb
ISR-GEO Med Res Clin Healthycore, Tbilisi
"LLC Todua Clinic", Tbilisi
JSC KE Nat Ctr of Exp and Clin Surg, Tbilisi
SRH Wald-Klinikum Gera gGmbH, Gera
Istituto Dermopatico dell'Immacolata (IDI) - IRCCS, Roma
Nagoya City University Hospital - Dermatology, Nagoya
Sapporo Medical University Hospital, Sapporo
NHO Kagoshima Medical Center, Kagoshima
Shizuoka Cancer Center - Dermatology, Kōtoku
Keio University Hospital - Dermatology, Shinjuku-ku
Kumamoto University Hospital - Dermatology, Kumamoto
Niigata Cancer Center Hospital, Niigata
Osaka International Cancer Institute - Dermatological Oncology, Osaka
IMSP Institutul Oncologic, ARENSIA, Chisinau
Amphia Ziekenhuis (Amphia Hospital Breda) - Locatie Molengracht, Breda
Arensia - Iob, Bucharest
Mary Potter Oncology Centre, Pretoria
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol, Badalona
Hospital de La Santa Creu i Sant Pau, Barcelona
Hospital Universitari Vall D Hebron, Barcelona
Hospital Clinic De Barcelona, Barcelona
Lead Sponsor
Amgen
INDUSTRY